Your browser doesn't support javascript.
loading
Nivolumab in refractory cerebral relapse of Hodgkin's lymphoma.
Lapierre, Leopoldine; Pericart, Sarah; Protin, Caroline; Borel, Cecile; Ysebaert, Loic; Laurent, Camille; Oberic, Lucie.
Afiliação
  • Lapierre L; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France.
  • Pericart S; Department of Pathology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France.
  • Protin C; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France.
  • Borel C; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France.
  • Ysebaert L; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France.
  • Laurent C; Department of Pathology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France.
  • Oberic L; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, France.
Leuk Lymphoma ; 62(12): 3063-3065, 2021 12.
Article em En | MEDLINE | ID: mdl-34254883
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados Idioma: En Ano de publicação: 2021 Tipo de documento: Article